Drug Discovery and Development
Course, Master's level, 3FK229
Autumn 2024 Autumn 2024, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 2 September 2024–2 October 2024
- Language of instruction
- English
- Entry requirements
-
150 credits of which 120 credits in biomedicine, pharmaceutical science, natural science and/or technology. Prior studies should include 10 credits in chemistry and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 April 2024
- Application code
- UU-35004
Admitted or on the waiting list?
- Registration period
- 25 July 2024–25 August 2024
- Information on registration
Autumn 2024 Autumn 2024, Uppsala, 100%, On-campus, English For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 2 September 2024–2 October 2024
- Language of instruction
- English
- Entry requirements
-
150 credits of which 120 credits in biomedicine, pharmaceutical science, natural science and/or technology. Prior studies should include 10 credits in chemistry and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
- Registration period
- 25 July 2024–25 August 2024
- Information on registration
Spring 2025 Spring 2025, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 20 January 2025–20 February 2025
- Language of instruction
- English
- Entry requirements
-
150 credits of which 120 credits in biomedicine, pharmaceutical science, natural science and/or technology. Prior studies should include 10 credits in chemistry and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 October 2024
- Application code
- UU-85004
Admitted or on the waiting list?
Spring 2025 Spring 2025, Uppsala, 100%, On-campus, English For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 20 January 2025–20 February 2025
- Language of instruction
- English
- Entry requirements
-
150 credits of which 120 credits in biomedicine, pharmaceutical science, natural science and/or technology. Prior studies should include 10 credits in chemistry and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
About the course
The course deals with different phases in drug development; identification and validation of target molecule (the target), identification and optimisation of active substance, ADME-Tox profiling, in-vivo and in-vitro pharmacology, formulation, discovery and biomarkers and disease models, clinical trials, registration and commercialisation.